Pub. Date : 2005 Apr
PMID : 15818702
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | OBJECTIVE: To assess the efficacy, safety, and tolerability of etoricoxib, a cyclooxygenase 2 (COX-2) selective inhibitor, administered continuously over 52 weeks for the treatment of ankylosing spondylitis (AS). | Etoricoxib | prostaglandin-endoperoxide synthase 2 | Homo sapiens |
2 | OBJECTIVE: To assess the efficacy, safety, and tolerability of etoricoxib, a cyclooxygenase 2 (COX-2) selective inhibitor, administered continuously over 52 weeks for the treatment of ankylosing spondylitis (AS). | Etoricoxib | prostaglandin-endoperoxide synthase 2 | Homo sapiens |